MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2021

    COMPARISON OF FREQUENCY, CLINICAL PROFILE AND ETIOLOGIES OF PARKINSONISM IN 2008 AND 10 YEARS LATER AT THE NEUROLOGY DEPARTMENT OF BEFELATANANA UNIVERSITY TEACHING HOSPITAL, ANTANANARIVO, MADAGASCAR

    NF. Rasaholiarison, M. Ratsimandresy, JL. Rakotomanana, A. Tehindrazanarivelo (Fianarantsoa, Madagascar)

    Objective: To compare the frequency, the clinical profile of parkinsonism and its etiologies in 2008 and 10 years later in our department. Background: Number of…
  • MDS Virtual Congress 2021

    Comprehensive analysis of PRKN in a large Parkinson’s Disease cohort identifies causative mutations and validates population scale screening by microarray

    W. Zhu, X. Huang, E. Yoon, S. Bandres-Ciga, C. Blauwendraat, J. Cade, B. Wu, J. Brooks, J. Gibbs, D. Hernandez, D. Ehrlich, A. Singleton, D. Narendra (Bethesda, USA)

    Objective: To screen for PRKN mutations at the population scale. Background: PRKN mutations are the most common recessive cause of Parkinson’s disease (PD) and are…
  • MDS Virtual Congress 2021

    Autonomic Symptoms as Predictors of Quality of Life in Parkinson’s Disease: A 5-year follow up study

    A. Bougea, S. Pantinaki, A. Antonoglou, P. Giannaki, F. Efthymiopoulou (Athens, Greece)

    Objective: The aim of this study was to investigate whether the autonomic symptoms could predict the quality of life of patients with PD. Background: Parkinson's…
  • MDS Virtual Congress 2021

    ‘Asymmetric thumb-index angle’ in PD: A new observation in an old disease

    J. Siddiqui (Columbia, USA)

    Objective: To report a novel sign on inspection in PD that is present throughout different dopaminergic states Background: Inspection is arguably one of the most…
  • MDS Virtual Congress 2021

    Prevalence of Parkinsonism and Parkinson Disease in urban and rural populations in Latin America.

    J. Llibre-Guerra, M. Prina, A. Sosa, D. Acosta, I. Jimenez-Velasquez, M. Guerra, A. Salas, A. Rodriguez-Salgado, J. Llibre-Guerra, G. Peters, I. Acosta, J. Juncos, J. Llibre-Rodriguez (La Habana, Cuba)

    Objective: To estimate the prevalence and risk factors of parkinsonism and Parkinson Disease in elderly individuals from Latin America. Background: Parkinson’ s disease (PD) is…
  • MDS Virtual Congress 2021

    Emotional, logistical and ethical aspects of voluntarily stopping eating and drinking in patients with movement disorders

    J. Shurer, M. Buchbinder, N. Browner (Chapel Hill, USA)

    Objective: We present two patients with atypical parkinsonism who chose to die by voluntarily stopping eating and drinking (VSED) to highlight the unique support and care needs associated…
  • MDS Virtual Congress 2021

    Validation of a real- time monitoring system to detect motor symptoms in patients with Parkinson´s disease treated with Levodopa Carbidopa Intestinal Gel

    A. Bougea, M. Palkopoulou, S. Pantinaki, A. Antonoglou, E. Efthymiopoulou (Athens, Greece)

    Objective: Our aim was to analyze the ability of system to combine information on OFF periods, falls and dyskinesias of patients with PD. Background: Levodopa…
  • MDS Virtual Congress 2021

    Unusual Progressive Supranuclear Palsy: a case report

    L. Megherbi, H. Si Ahmed, S. Daoudi (Tizi Ouzou, Algeria)

    Objective: Introduction: Progressive supranuclear palsy (PSP) is a rare brain condition. It is predominantly a sporadic disease that occurs between 45 and 75 years of…
  • MDS Virtual Congress 2021

    Time to diagnosis of clinically established Parkinson’s disease or atypical parkinsonism: is a 5-year follow-up period necessary?

    M. Rossi, S. Perez-Lloret, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the time frame to the diagnosis of clinically established Parkinson’s disease (PD) or atypical parkinsonism after an acute levodopa challenge (LDC) for…
  • MDS Virtual Congress 2021

    Plasma and fecal short chain fatty acids as predictors for the risk and severity of Parkinson’s Disease

    SJ. Chen, SY. Liao, YT. Lin, CH. Kuo, CH. Lin (Taipei City, Taiwan)

    Objective: To delineate the influence of plasma and fecal short chain fatty acids (SCFAs) on the risk and severity of Parkinson’s disease (PD). Background: Recent…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley